Suppr超能文献

体重波动与心血管疾病、全因死亡率和心血管死亡率风险增加相关:一项系统评价和荟萃分析

Body-Weight Fluctuation Was Associated With Increased Risk for Cardiovascular Disease, All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-Analysis.

作者信息

Zou Huajie, Yin Ping, Liu Liegang, Liu Wenhua, Zhang Zeqing, Yang Yan, Li Wenjun, Zong Qunchuan, Yu Xuefeng

机构信息

Division of Endocrinology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

Front Endocrinol (Lausanne). 2019 Nov 8;10:728. doi: 10.3389/fendo.2019.00728. eCollection 2019.

Abstract

The aim of this study was to evaluate associations between body-weight fluctuation and risk of mortality and cardiovascular diseases (CVD). PubMed, EMBASE databases and Cochrane Library were searched for cohort studies published up to May 20, 2019, reporting on associations of body-weight fluctuation and mortality from all causes, CVD and cancer, as well as morbidity of CVD and hypertension. Summary relative risks (RRs) were estimated using a random-effects model. Twenty-five eligible publications from 23 studies with 441,199 participants were included. Body-weight fluctuation was associated with increased risk for all-cause mortality (RR, 1.41; 95% confidence interval (CI): 1.27-1.57), CVD mortality (RR, 1.36; 95% CI 1.22-1.52), and morbidity of CVD (RR, 1.49, 95% CI 1.26-1.76) and hypertension (RR, 1.35, 95% CI 1.14-1.61). However, there was no significant association between weight fluctuation and cancer mortality (RR, 1.01; 95% CI 0.90-1.13). No evidence of publication bias was observed (all > 0.05) except for studies on all-cause mortality (Egger's test, = 0.001; Begg's test, = 0.014). Body-weight fluctuation was associated with higher mortality due to all causes and CVD and a higher morbidity of CVD and hypertension.

摘要

本研究旨在评估体重波动与死亡率及心血管疾病(CVD)风险之间的关联。检索了PubMed、EMBASE数据库和Cochrane图书馆,查找截至2019年5月20日发表的队列研究,这些研究报告了体重波动与全因死亡率、CVD和癌症死亡率以及CVD和高血压发病率之间的关联。使用随机效应模型估计汇总相对风险(RRs)。纳入了来自23项研究的25篇符合条件的出版物,涉及441,199名参与者。体重波动与全因死亡率增加(RR,1.41;95%置信区间(CI):1.27 - 1.57)、CVD死亡率增加(RR,1.36;95% CI 1.22 - 1.52)、CVD发病率增加(RR,1.49,95% CI 1.26 - 1.76)和高血压发病率增加(RR,1.35,95% CI 1.14 - 1.61)相关。然而,体重波动与癌症死亡率之间无显著关联(RR,1.01;95% CI 0.90 - 1.13)。除全因死亡率研究外,未观察到发表偏倚的证据(所有P>0.05)(Egger检验,P = 0.001;Begg检验,P = 0.014)。体重波动与全因和CVD导致的较高死亡率以及CVD和高血压的较高发病率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa0f/6856014/97a406c6f5c7/fendo-10-00728-g0001.jpg

相似文献

2
3
4
Asthma and risk of cardiovascular disease or all-cause mortality: a meta-analysis.
Ann Saudi Med. 2017 Mar-Apr;37(2):99-105. doi: 10.5144/0256-4947.2017.99.
5
Association Between Gallstone Disease and Risk of Mortality of Cardiovascular Disease and Cancer: A Systematic Review and Meta-Analysis.
Cardiovasc Hematol Disord Drug Targets. 2024;24(1):47-58. doi: 10.2174/011871529X298791240607041246.
10
Beta-blockers for hypertension.
Cochrane Database Syst Rev. 2017 Jan 20;1(1):CD002003. doi: 10.1002/14651858.CD002003.pub5.

引用本文的文献

2
Knowledge and Attitudes Regarding a Weight-Neutral Approach to Health Promotion in Primary Care Settings.
Cureus. 2025 May 7;17(5):e83632. doi: 10.7759/cureus.83632. eCollection 2025 May.
3
Increasing the health span: unique role for exercise.
J Appl Physiol (1985). 2025 Jun 1;138(6):1285-1308. doi: 10.1152/japplphysiol.00049.2025. Epub 2025 Apr 17.
6
Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs.
Obes Pillars. 2024 Jul 25;11:100121. doi: 10.1016/j.obpill.2024.100121. eCollection 2024 Sep.
7
Type 2 Diabetes Incidence and Mortality: Associations with Physical Activity, Fitness, Weight Loss, and Weight Cycling.
Rev Cardiovasc Med. 2022 Oct 25;23(11):364. doi: 10.31083/j.rcm2311364. eCollection 2022 Nov.
8
Cohort profile: The Obesity and Disease Development Sweden (ODDS) study, a pooled cohort.
BMJ Open. 2024 Jul 16;14(7):e084836. doi: 10.1136/bmjopen-2024-084836.
9
Role of the intestinal microbiota in contributing to weight disorders and associated comorbidities.
Clin Microbiol Rev. 2024 Sep 12;37(3):e0004523. doi: 10.1128/cmr.00045-23. Epub 2024 Jun 28.
10
The association of body mass index variability with cardiovascular disease and mortality: a mediation analysis of pooled cohorts.
Front Endocrinol (Lausanne). 2024 May 13;15:1345781. doi: 10.3389/fendo.2024.1345781. eCollection 2024.

本文引用的文献

1
Association of Weight Fluctuation With Mortality in Japanese Adults.
JAMA Netw Open. 2019 Mar 1;2(3):e190731. doi: 10.1001/jamanetworkopen.2019.0731.
3
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK.
Lancet Diabetes Endocrinol. 2018 Dec;6(12):944-953. doi: 10.1016/S2213-8587(18)30288-2. Epub 2018 Oct 30.
4
Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.
Circ Res. 2018 Sep 14;123(7):886-904. doi: 10.1161/CIRCRESAHA.118.312806.
6
Increased risk of diabetes development in individuals with weight cycling over 4 years: The Kangbuk Samsung Health study.
Diabetes Res Clin Pract. 2018 May;139:230-238. doi: 10.1016/j.diabres.2018.03.018. Epub 2018 Mar 21.
7
Body-Weight Fluctuations and Outcomes in Coronary Disease.
N Engl J Med. 2017 Apr 6;376(14):1332-1340. doi: 10.1056/NEJMoa1606148.
9
Weight Change and All-Cause Mortality in Older Adults: A Meta-Analysis.
J Nutr Gerontol Geriatr. 2015;34(4):343-68. doi: 10.1080/21551197.2015.1090362.
10
Intentional weight loss and all-cause mortality: a meta-analysis of randomized clinical trials.
PLoS One. 2015 Mar 20;10(3):e0121993. doi: 10.1371/journal.pone.0121993. eCollection 2015.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验